{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:06Z","timestamp":1786119426757,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/01.npr.0000368900.15700.ea","type":"journal-article","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T02:26:34Z","timestamp":1266373594000},"page":"9-10","source":"Crossref","is-referenced-by-count":0,"title":["Febuxostat provides new gout treatment option"],"prefix":"10.1097","volume":"35","author":[{"given":"Jennifer M.","family":"Belavic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210130","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clindermatol.2006.07.015","article-title":"Metabolic disease: gout.","volume":"24","author":"Falasca","year":"2006","journal-title":"Clin Dermato"},{"key":"R2-3-20210130","first-page":"198","article-title":"Refractory gout: what is it and what to do about it Curr Opin Rheumatol.","volume":"20","author":"Fels","year":"2008","journal-title":""},{"key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/BOR.0b013e32802106b9","article-title":"Therapeutic advances in gout.","volume":"19","author":"Pascual","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1345\/aph.1H121","article-title":"Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.","volume":"40","author":"Bruce","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R5-3-20210130","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout.","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-3-20210130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11926-007-0041-y","article-title":"Uricase and other novel agents for the management of patients with treatment-failure gout.","volume":"9","author":"Sundy","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/rheumatology\/kem178","article-title":"Assessment of outcome in clinical trials of gout - a review of current measures.","volume":"46","author":"Taylor","year":"2007","journal-title":"Rheumatology"},{"key":"R8-3-20210130","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum (Arthritis Care Research)"},{"key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/rheumatology\/ken457","article-title":"Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.","volume":"48","author":"Schumacher","year":"2009","journal-title":"Rheumatology"}],"container-title":["The Nurse Practitioner"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006205-201003000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:12:52Z","timestamp":1786039972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006205-201003000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/01.npr.0000368900.15700.ea","relation":{},"ISSN":["0361-1817"],"issn-type":[{"value":"0361-1817","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}